Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|July 22, 2025
Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOSNasheed M Hossain, Kwang Woo Ahn, Jinalben Patel, et al.
Transplantation and Cellular Therapy|October 13, 2024
Addition of Nivolumab Tailored by Expansion of CAR-T Cells in Patients with Stable/Progressive Large B Cell Lymphoma at Lymphodepletion-A Phase 2, Prospective Interventional StudyRon Ram, Odelia Amit, Chava Perry, et al.
Blood Advances|March 4, 2026
OUTCOMES OF PATIENTS OVER 70 YEARS TREATED WITH BREXU-CEL FOR R/R MANTLE CELL LYMPHOMA: A STUDY FROM THE CTIWP OF EBMTNicole Santoro, Jarl Eduard Mooyaart, Urban Novak, et al.
Bone Marrow Transplantation|May 27, 2026
Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMTAnnalisa Paviglianiti, Maud Ngoya, Regis Peffault de la Tour, et al.
Transplantation and Cellular Therapy|April 15, 2024
Listeria monocytogenes Infections in Hematopoietic Cell Transplantation Recipients: Clinical Manifestations and Risk Factors. A Multinational Retrospective Case-Control Study from the Infectious Diseases Working Party of the European Society for Blood and Marrow TransplantationDina Averbuch, Gloria Tridello, Lotus Wendel, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 9, 2023
Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effectsSuzy E Meijer, Ora Halutz, Amos Adler, et al.
Blood Reviews|February 22, 2025
The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMTSimona Pagliuca, Florent Malard, Jarl E Mooyaart, et al.
Annals of Hematology|January 27, 2022
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysisIrit Avivi, Chava Perry, Yafit Segman, et al.
Hemasphere|May 22, 2025
Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalitionAnna Ossami Saidy, Christophe Peczynski, Catherine Thieblemont, et al.
Blood Cancer Journal|July 8, 2024
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remissionMazyar Shadman, Kwang W Ahn, Manmeet Kaur, et al.
Pageof 13